Impact of a genomic classifier on indeterminate thyroid nodules: an institutional experience
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 10 (2) , 155-163
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodulesCancer, 2018
- The 2017 Bethesda System for Reporting Thyroid CytopathologyThyroid®, 2017
- THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancerProceedings of the National Academy of Sciences, 2017
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate CytologyThe Journal of Clinical Endocrinology & Metabolism, 2015
- Integrated Genomic Characterization of Papillary Thyroid CarcinomaCell, 2014
- Multicenter Clinical Experience With the Afirma Gene Expression ClassifierThe Journal of Clinical Endocrinology & Metabolism, 2014
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2013
- The Bethesda System for Reporting Thyroid Cytopathology: A Meta-AnalysisActa Cytologica, 2012
- Update in Thyroid Fine Needle AspirationEndocrine Pathology, 2011